Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01040650 · ClinicalTrials.gov registry record
Metabolic Features of Post-Myopathy Patients Associated With Statin Treatment
A clinical trial, sponsored by Rockefeller University.
- Terminated
- Registry status
- 23
- Enrollment target
NCT01040650 is a clinical trial that was terminated before completion, run by Rockefeller University. The registered enrollment target is 23 participants.
The verdict
NCT01040650 was terminated before completion, sponsored by Rockefeller University.
- TERMINATED
- Registry status
- 23 participants
- Enrollment target
Study Summary
Statins are a class of drugs given to lower cholesterol. Although statins are considered to be generally safe, some studies show that about 10% of people on statins develop muscle-related symptoms, from fatigue (tiredness), weakness, cramping, pain and sometimes a lifethreatening muscle breakdown condition known as rhabdomyolysis. In some, these symptoms may greatly affect their daily activities. One consideration why symptoms develop in only some patients is that they may have an underlying problem in the way their muscles use fats to produce energy. In these patients, the muscles are not able to fully utilize fats and so they become tired more easily. Fat within the muscle can also affect how your body uses a hormone called insulin, which affects your blood sugar levels. The investigators are specifically interested in previous statin users and determine if the muscle symptoms are related to changes in energy and sugar use. We propose to enroll patients who have developed muscle side effects on previous statin treatment and have since discontinued statin treatment. Our aim is to compare the metabolic parameters in these patients to age and gender-matched normal individuals.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2009-08 |
| Est. Completion | 2012-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01040650
The ClinicalTrials.gov registry entry for NCT01040650 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rockefeller University, which has 117 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01040650 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01040650 about?
NCT01040650 is a clinical study titled "Metabolic Features of Post-Myopathy Patients Associated With Statin Treatment". Statins are a class of drugs given to lower cholesterol. Although statins are considered to be generally safe, some studies show that about 10% of people on statins develop muscle-related symptoms, from fatigue (tiredness), weakness, cramping, pain and sometimes a lifethreatening muscle breakdown co...
What is the current status of trial NCT01040650?
This trial is currently terminated. The enrollment target is 23 participants. The study started on 2009-08. Estimated completion is 2012-01.
Who is sponsoring clinical trial NCT01040650?
This trial is sponsored by Rockefeller University, which has 117 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.